Belton Family Practice Clinic Llc | |
204 E North Ave Belton MO 64012-2013 | |
(816) 331-7744 | |
Not Available |
Full Name | Belton Family Practice Clinic Llc |
---|---|
Speciality | Family Medicine |
Location | 204 E North Ave, Belton, Missouri |
Authorized Official Name and Position | Mickey S Pickler (VICE PRESIDENT) |
Authorized Official Contact | 8165084039 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Belton Family Practice Clinic Llc 204 E North Ave Belton MO 64012-2013 Ph: (816) 331-7744 | Belton Family Practice Clinic Llc 204 E North Ave Belton MO 64012-2013 Ph: (816) 331-7744 |
NPI Number | 1477500221 |
---|---|
Provider Enumeration Date | 05/27/2006 |
Last Update Date | 10/17/2017 |
Medicare PECOS PAC ID | 5193717601 |
---|---|
Medicare Enrollment ID | O20040402000151 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1477500221 | NPI | - | NPPES |
100452550A | Medicaid | KS | |
506091404 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
Provider Name | Ossama Al-assafeen |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1912078452 PECOS PAC ID: 9638117906 Enrollment ID: I20050419000423 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | Kent A Bogner |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1295720340 PECOS PAC ID: 5799725743 Enrollment ID: I20050509000969 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | Cassandra L Brewster |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1801826193 PECOS PAC ID: 3072528413 Enrollment ID: I20060207000444 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | David R Williams |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1275528895 PECOS PAC ID: 0042348898 Enrollment ID: I20100514000591 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | Kirk D Ridley |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1922093954 PECOS PAC ID: 1557499324 Enrollment ID: I20100514000788 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | Logan F Kratt |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1467461558 PECOS PAC ID: 4587856778 Enrollment ID: I20101006000633 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | Zandra R Gottman |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1235529512 PECOS PAC ID: 4789903493 Enrollment ID: I20150430002429 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Provider Name | Kristin Angele Smith |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1215324165 PECOS PAC ID: 9133431398 Enrollment ID: I20150701001482 |
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
News Archive
A new systematic analysis of the relationship between the neoplastic and developmental transcriptome provides an outline of trends in cancer gene expression. The research, published recently in BioMed Central's open access journal Genome Biology, describes how cancers can be divided into three groups distinguished by disparate developmental signatures.
One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the cell about how to behave
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today.
› Verified 5 days ago
Wound Solutions Of Kansas City Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7926 E 171st St Ste 111, Belton, MO 64012 Phone: 214-422-8172 | |
Careatc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 820 Quik Trip Way, Belton, MO 64012 Phone: 800-993-8244 | |
Ltc Consultants Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 16201 Bluegrass Ct, Belton, MO 64012 Phone: 816-695-3135 | |
Midwest Medicine Associates Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17053 S 71 Hwy, Suite 101, Belton, MO 64012 Phone: 816-322-0650 | |
Serc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 17134 Bel Ray Pl, Belton, MO 64012 Phone: 816-318-0436 Fax: 816-318-0437 | |
Swope Health Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 204 E North Ave, Belton, MO 64012 Phone: 816-932-5800 |